AstraZeneca plan to beef up CEO Soriot’s pay packet faces scrutiny at AGM

A number of investor advisory groups have called on AstraZeneca (AZN.L) shareholders to oppose plans to increase Chief Executive Pascal Soriot’s pay package when the COVID-19 vaccine maker holds its annual meeting on Tuesday.